Home / Market News / $SMR
benzinga Corporate Catalyst Impact 85/100 ● negative

NuScale Stock Hits New Low After Barclays Downgrades It to Underweight, Cuts Target to $5

Oct 20, 2026, 12:51 PM UTC · Primary ticker $SMR

Barclays downgraded NuScale Power (SMR) to Underweight from Equal Weight and slashed its price target to $5 from $11, citing mounting execution risks and commercial development delays. This downgrade, following other bearish analyst calls and dilution concerns, has sent NuScale shares to a new low, reflecting significant negative sentiment and increased investor caution.

Barclays' significant downgrade of NuScale Power (SMR) to Underweight with a drastic price target cut to $5 from $11 is a major negative catalyst. The firm cited mounting execution risks, delays in commercial development, and contract uncertainty, echoing concerns from other analysts like UBS and RBC Capital. This news directly impacts NuScale shareholders, leading to a sharp decline in the stock price and pushing it to a new 52-week low. In the short term, SMR is likely to face continued selling pressure as investor confidence erodes. Long-term implications include increased scrutiny on the company's ability to secure contracts and manage its cash burn, especially given its minimal revenue and substantial projected cash needs. The key risk for traders is further downside if commercial progress remains slow or if dilution concerns intensify.

$SMR negative Analyst downgrade, price target cut, execution risks, dilution concerns
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.